Biomatter
Vilnius
About Biomatter
Biomatter is a synthetic biology company that develops new proteins used in medicine and sustainable manufacturing. The company created the Intelligent Architecture platform, which addresses the limitations of current engineering approachestoo open up completely new horizons for protein design and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.7M
- Funding stage: Seed
- Last round: Seed (Aug 2024)
- Website: biomatter.ai
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biomatter-72854 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.